BDX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 16:00):

Stats
Today's Volume	2.03M
Average Volume	1.35M
Market Cap	68.11B
EPS	$0 ( 2024-05-02 )
Next earnings date	( $3.32 ) 2024-08-01
Last Dividend	$0.950 ( 2024-03-07 )
Next Dividend	$0 ( N/A )
P/E	50.46
ATR14	$0.176 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-03	Byington Carrie L	Buy	129	Rights to Common Stock Under BD Deferred Compensation Plan
2024-05-03	Jones Christopher Ian Montague	Buy	129	Rights to Common Stock Under BD Deferred Compensation Plan
2024-04-30	Garrison Michael David	Sell	1 715	Common Stock
2024-04-04	Neal Shana Carol	Sell	1 921	Common Stock
2024-03-14	Spoerel Thomas J	Sell	282	Common Stock

INSIDER POWER
68.46
Last 100 transactions
Buy: 255 893 \| Sell: 56 118

Volume Correlation

Long: 0.03 (neutral)

Short: -0.78 (moderate negative)

Signal:(51.621) Neutral

Becton Dickinson and Co Correlation

10 Most Positive Correlations
AGQ	0.901
SLV	0.889
SIVR	0.888
PSLV	0.881
SO	0.88
KMB	0.88
LLY	0.864
TDI	0.855
NVS	0.853
PG	0.833

10 Most Negative Correlations
ZSL	-0.861
INSW	-0.854
AYI	-0.853
NM	-0.838
TNP	-0.83
STAR	-0.827
TEX	-0.823

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Becton Dickinson and Co Correlation - Currency/Commodity

-0.05
( neutral )

0.28
( neutral )

0.22
( neutral )

-0.33
( neutral )

-0.47
( neutral )

Becton Dickinson and Co Financials

Annual	2023
Revenue:	$19.37B
Gross Profit:	$8.17B (42.17 %)
EPS:	$4.97

FY	2023
Revenue:	$19.37B
Gross Profit:	$8.17B (42.17 %)
EPS:	$4.97

FY	2022
Revenue:	$18.87B
Gross Profit:	$8.48B (44.92 %)
EPS:	$5.93

FY	2021
Revenue:	$20.25B
Gross Profit:	$9.43B (46.56 %)
EPS:	$6.92

Financial Reports:

No articles found.

Becton Dickinson and Co Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.870 (N/A)	$0.910 (N/A)	$0.910 (N/A)	$0.910 (N/A)	$0.910 (N/A)	$0.950 (N/A)	$0.950 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Becton Dickinson and Co Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.16 - Stable (16.80%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0213	1973-02-28
Last Dividend	$0.950	2024-03-07
Next Dividend	$0	N/A
Payout Date	2024-03-29
Next Payout Date	N/A
# dividends	165	--
Total Paid Out	$47.51	--
Avg. Dividend % Per Year	1.05%	--
Score	5.1	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.16
Div. Directional Score	7.26	--

Next Divdend (Est)
(2024-09-09)

$0.960 Estimate 60.01 %

Dividend Stability

0.96 Excellent

Dividend Score

5.10

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1973	$0.0213	0.94%
1974	$0	0.00%
1975	$0	0.00%
1976	$0	0.00%
1977	$0	0.00%
1978	$0	0.00%
1979	$0	0.00%
1980	$0	0.00%
1981	$0	0.00%
1982	$0	0.00%
1983	$0.0525	2.00%
1984	$0.0716	3.11%
1985	$0.0750	3.10%
1986	$0.0829	2.18%
1987	$0.0940	1.52%
1988	$0.109	1.74%
1989	$0.124	1.99%
1990	$0.134	1.76%
1991	$0.143	1.57%
1992	$0.150	1.85%
1993	$0.166	1.75%
1994	$0.187	2.13%
1995	$0.210	1.78%
1996	$0.232	1.25%
1997	$0.229	1.08%
1998	$0.295	1.21%
1999	$0.339	0.81%
2000	$0.365	1.43%
2001	$0.374	1.12%
2002	$0.384	1.18%
2003	$0.439	1.43%
2004	$0.614	1.53%
2005	$0.738	1.35%
2006	$0.869	1.47%
2007	$0.995	1.45%
2008	$1.156	1.37%
2009	$1.327	1.95%
2010	$1.493	1.95%
2011	$1.669	2.02%
2012	$1.800	2.48%
2013	$1.981	2.56%
2014	$2.18	2.05%
2015	$2.40	1.76%
2016	$2.64	1.83%
2017	$2.87	1.78%
2018	$2.95	1.39%
2019	$3.02	1.41%
2020	$3.12	1.17%
2021	$3.28	1.34%
2022	$3.50	1.42%
2023	$3.68	1.44%
2024	$0.950	0.39%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0676	1.500	8.65	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0246	1.200	9.18	10.00	[0 - 0.3]
returnOnEquityTTM	0.0519	1.500	-0.534	-0.801	[0.1 - 1]
payoutRatioTTM	0.826	-1.000	1.740	-1.740	[0 - 1]
currentRatioTTM	1.411	0.800	7.94	6.36	[1 - 3]
quickRatioTTM	0.789	0.800	-0.0655	-0.0524	[0.8 - 2.5]
cashRatioTTM	0.327	1.500	9.30	10.00	[0.2 - 2]
debtRatioTTM	0.333	-1.500	4.46	-6.69	[0 - 0.6]
interestCoverageTTM	8.79	1.000	7.85	7.85	[3 - 30]
operatingCashFlowPerShareTTM	12.99	2.00	5.67	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.45	2.00	4.77	9.55	[0 - 20]
debtEquityRatioTTM	0.702	-1.500	7.19	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.412	1.000	6.46	6.46	[0.2 - 0.8]
operatingProfitMarginTTM	0.110	1.000	9.80	9.80	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.209	1.000	9.95	9.95	[0.2 - 2]
assetTurnoverTTM	0.364	0.800	-0.906	-0.725	[0.5 - 2]
Total Score				10.36

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	51.19	1.000	4.93	0	[1 - 100]
returnOnEquityTTM	0.0519	2.50	-0.343	-0.801	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.45	2.00	6.52	9.55	[0 - 30]
dividendYielPercentageTTM	1.578	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	12.99	2.00	5.67	10.00	[0 - 30]
payoutRatioTTM	0.826	1.500	1.740	-1.740	[0 - 1]
pegRatioTTM	0.219	1.500	-1.876	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.191	1.000	7.73	0	[0.1 - 0.5]
Total Score				4.16

Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.